Patents Examined by Manuel Mendez
  • Patent number: 11957876
    Abstract: An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: April 16, 2024
    Assignee: BETA BIONICS, INC.
    Inventors: Edward B. Raskin, David Chi-Wai Lim, Michael J. Rosinko, Firas H. El-Khatib, Edward R. Damiano
  • Patent number: 11951262
    Abstract: Catheters, sheaths, or other tubular devices are provided that include a proximal end, a distal end sized for introduction into a patient's body, and a steerable distal portion. The tubular device includes a primary lumen extending between the proximal and distal ends; an auxiliary lumen adjacent the primary lumen; and one or more reinforcement members including windings extending helically along at least the distal portion, at least some of the windings passing between the primary and steering element lumens and at least some of the windings surrounding both the primary and steering element lumens. In one embodiment, a steering element is slidably disposed within the auxiliary lumen. Apparatus and methods for making such tubular devices are also provided.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: April 9, 2024
    Assignee: CLPH, LLC
    Inventors: Stephen A. Leeflang, Christian S. Eversull
  • Patent number: 11951246
    Abstract: A method of coaching a patient to use an inhaler for medication delivery is provided. The method includes obtaining, via a sensor, respiratory behavior data of the patient; receiving, at a computing device, the respiratory behavior data; performing a respiratory pattern analysis algorithm on the respiratory behavior data to determine a desired interval of inhaler actuation for medication delivery; communicating a cue signal to actuate the inhaler to achieve the desired interval; obtaining, via the sensor, inhaler actuation data based on the actuation of the inhaler; receiving, at the computing device, the inhaler actuation data; performing an actuation analysis algorithm on the inhaler actuation data to assess the efficacy of the actuation; and adjusting the cue signal to actuate the inhaler to improve the efficacy of a future actuation.
    Type: Grant
    Filed: September 27, 2023
    Date of Patent: April 9, 2024
    Assignee: Yale University
    Inventor: Peter Kahn
  • Patent number: 11944785
    Abstract: Devices, systems, and techniques for therapy delivery and healthcare management is described. In one example, a system comprises a delivery device configured to execute therapy information comprising a treatment schedule specifying one or more treatments over a time period, wherein for each of the one or more treatments, the therapy information comprises a treatment type and a treatment amount; and processing circuitry configured to: determine a modification to the therapy information based on a recommendation of a digital twin, wherein the digital twin determines an estimated glucose level expected to be within a healthy range if the delivery device executes the modification to therapy information; and in response to physician review of the modification to the therapy information, output, to a healthcare provider system for the patient, data indicating completion of a healthcare service corresponding to the physician review.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: April 2, 2024
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Louis J. Lintereur, Catherine Tan Fogel, Patrick E. Weydt, Benyamin Grosman, Mahta Sadeghzadeh
  • Patent number: 11944178
    Abstract: A system and method for dermal spraying includes a portable, hand-held dermal application device with disposable formulation capsules that spray a formulation unto the skin and a data transmission unit operatively connecting the dermal spray device to a mobile device. The mobile device communicates with a remote server and transmits anonymized data about the user's skin conditions and treatment history. The anonymized data may be labelled and classified by a dermatologist, and stored on a secure cloud server. The anonymized data is used to train models for serum and treatment plan recommenders.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: April 2, 2024
    Assignee: Kozhya LLC SP Z.O.O.
    Inventors: Yoanna Gouchtchina, Enrique Gallar
  • Patent number: 11944771
    Abstract: The invention claims a new type of handheld medical device is meant to help the medical community by enabling them to treat patients remotely. This solves the problem of patient suffering or death due to lack of access to a medical professional or long wait times by enabling a patient-centred response to diseases, such as COVID-19. The device is hand-held, with incorporated germicidal UVC lights, an internal application tip and the delivery mechanism focuses on the mucous membrane. The top chamber connects to a removable container which can be used with the prescribed treatment/therapy, vaccine, or viral testing fluid/reagent, as needed. The versatility, non-invasive nature and germicidal properties constitute distinct improvements over other similar medical devices. This device also promotes the development of non-invasive inoculation and drug delivery systems via the mucous membrane.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: April 2, 2024
    Inventor: Andrada Bucataru
  • Patent number: 11944400
    Abstract: Robotic Angioplasty and Endoluminar Surgery System to separate patient and operator by remotely moving guides and catheters during operations, composed of three or more elements, of which at least one disposable (nose), available in different versions, like for independent advancements and retractions of a balloon catheter (or stent) and relative guide and to their common axial rotation, or for moving a guide with a moving core or a catheter. The nose should be inserted into a non-sterile Slave placed near the patient, covered with sterile drapes, and with a combination of toothed wheels it translates all into three rotations controlled by three independent motors, possibly measuring the torque applied by the motors. By replacing the three angular gauges to the motors, a Master is obtained, controlled by a doctor by moving non-sterile tubes.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: April 2, 2024
    Inventors: Guido Danieli, Ciro Indolfi, Salvatore De Rosa, Domenico Battaglia, Giovanni De Gaetano, Gionata Fragomeni, Pasquale Francesco Greco, Gabriele Larocca, Michele Perrelli
  • Patent number: 11938302
    Abstract: An insulin patch control method and a device therefor are provided. An insulin patch control method and a device therefor are provided. The insulin patch control method according to one embodiment of the present invention comprises the steps of: obtaining, from an insulin patch, blood glucose information measured by a blood glucose sensor; inputting the obtained blood glucose information into a first neural network; estimating a pump parameter of the insulin patch on the basis of output data of the first neural network; and simulating the insulin patch by inputting the blood sugar information and the pump parameter into a second neural network.
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: March 26, 2024
    Assignee: EOFLOW CO., LTD.
    Inventors: Ian G. Welsford, Inwook Bin, Ho Min Jeon
  • Patent number: 11942202
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: March 26, 2024
    Assignee: Nudge BG, Inc.
    Inventor: Lane Desborough
  • Patent number: 11938260
    Abstract: An apparatus for guiding cannulation with a dialysis needle of an arteriovenous dialysis access graft subcutaneously implanted in a body of a subject. The guiding apparatus comprises an elongated body member comprising a base portion terminating in longitudinal edges, a distance between the longitudinal edges of the base portion being substantially equal to a lateral dimension of the aces graft, and an elongated tubular sleeve defining an pocket having a longitudinal dimension and a lateral dimension configured to receive the body member. The body member is adapted to be received in the pocket of the sleeve for securing adjacent the subcutaneous access graft such that the inner surface of the base portion is aligned with a cannulation point of the graft for guiding location of a needle insertion.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: March 26, 2024
    Assignee: InnAVasc Medical, Inc.
    Inventors: Shawn M. Gage, Jeffrey H. Lawson, Joseph Knight, Craig Nichols
  • Patent number: 11925788
    Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: March 12, 2024
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Firas H. El-Khatib, Himanshu Patel
  • Patent number: 11929165
    Abstract: A closed-loop control for a medical therapeutic system is disclosed that includes one or more processes or components for/in the medical therapeutic system, a controller configured to determine whether one or more operations of the process(es) or component(s) are within a corresponding safety envelope, and one or more sensors. The process(es)/component(s) are configured to deliver a controlled amount of a substance, energy or force to a patient. The sensor(s) are configured to measure or determine a value of a measurable parameter of the process(es)/component(s) and/or effected by the operation(s), and provide the value(s) of the measurable parameter(s) to the controller. The controller determines whether each of the operation(s) are within the corresponding safety envelope according to a corresponding function that mathematically describes the operation. The safety envelope corresponds to known safe values of the measurable parameter, or an unmeasured parameter based on the measurable parameter.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: March 12, 2024
    Assignee: Mast Medical Systems, Inc.
    Inventor: Charles Harrison Benton Caudill
  • Patent number: 11918783
    Abstract: Some embodiments an infusion pump system can be configured to modify alarm limit parameters as the user's insulin load increases or decreases. Moreover, in particular embodiments, the infusion pump system can be configured to provide a “missed bolus” or “missed meal” alarm in response to the user's blood glucose characteristics, the user's insulin load information, or the like.
    Type: Grant
    Filed: April 20, 2023
    Date of Patent: March 5, 2024
    Assignee: INSULET CORPORATION
    Inventor: Mark C. Estes
  • Patent number: 11918784
    Abstract: A medical liquid injection device includes a base body, a needle assembly mounted on the base body, a reservoir fluidly connected to the needle assembly and having a plunger therein, a driving unit that linearly moves the plunger, and an encoder unit disposed at an end of the driving unit to measure rotation of the driving unit.
    Type: Grant
    Filed: March 3, 2023
    Date of Patent: March 5, 2024
    Assignee: EOFLOW CO., LTD.
    Inventors: Seungha Kim, Hyunduk Roh, Seonhwan Kim, Daejong Park
  • Patent number: 11904142
    Abstract: A needleless injector is provided. The needleless injector includes a loading lever having a working arm part having a lever shaft, a towing member inserted inside the cylinder housing, a link having one end portion pin-coupled to the working arm part and the other end portion pin-coupled to the towing member, an inner cylinder inserted inside the cylinder housing, a spring inserted into the inner cylinder, an actuating head inserted into the inner cylinder in front of the spring and having a catching protrusion configured to be inserted into the slit, and a trigger means having a stopper head part configured to be able to be inserted into the slit of the inner cylinder and detached from the slit. Accordingly, the needleless injector can achieve a reduction in size and thickness by having a simple structure even with a lever for reloading integrally formed therein.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: February 20, 2024
    Inventor: Min Su Cho
  • Patent number: 11904140
    Abstract: The exemplary embodiments provide medicament delivery devices that use cost functions in their control systems to determine medicament dosages. The cost function may have a medicament cost component and a performance cost component. The exemplary embodiments may use cost functions having medicament cost components that scale asymmetrically for different ranges of inputs (i.e., different candidate medicament dosages). The variance in scaling for different input ranges provides added flexibility to tailor the medicament cost component to the user and thus provide better management of medicament delivery to the user and better conformance to a performance target. The exemplary embodiments may use a cost function that has a medicament cost component (such as an insulin cost component) of zero for candidate dosages for a range of candidate dosages (e.g., below a reference dosage).
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: February 20, 2024
    Assignee: INSULET CORPORATION
    Inventors: Joon Bok Lee, Yibin Zheng, Jason O'Connor, Trang Ly
  • Patent number: 11904138
    Abstract: Disclosed herein are techniques related to glucose level management without carbohydrate counting. The techniques may involve obtaining contextual information for a meal, predicting amounts of glucose to be absorbed into a bloodstream of the patient over a duration of time due to consumption of the meal based on the contextual information for the meal, determining one or more amounts of insulin to counteract effects of the predicted amounts of glucose, and affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: February 20, 2024
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Boyi Jiang, Yuxiang Zhong, Pratik J. Agrawal, Ali Dianaty
  • Patent number: 11890442
    Abstract: Systems and methods for detecting an implanted medical device, such as a vascular access port. The implanted medical device may include at least one passive RFID tag that has disposed thereon information about the implanted medical device. The at least one passive RFID tag is designed to be interrogated by a detector associated with an external device, such as an infusion set with an access needle. The interrogating signal induces a return signal from the at least one passive RFID tags. The strength of the return signal may be dependent on the distance and orientation of the tag relative to the detector. The system may be designed to interpret different signal strengths from different RFID tags to guide the needle to a correct insertion position, thereby accessing a port that cannot be readily detected visually or by palpation.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: February 6, 2024
    Assignee: Bard Peripheral Vascular, Inc.
    Inventor: Murtaza Y. Amin
  • Patent number: 11878136
    Abstract: A system, apparatus and method for a tightly sealed, low moisture vapor transmission, low relative humidity headspace atmosphere aseptic vaccine delivery with low particulate generation. The system can include a housing, desiccant and a biasing member designed to quickly and efficiently deliver medicament to a patient.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: January 23, 2024
    Assignee: CSP TECHNOLOGIES, INC.
    Inventors: Jean-Pierre Giraud, Franklin Lee Lucas, Jr., Bruce Rabinne
  • Patent number: 11872034
    Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: January 16, 2024
    Assignee: DEXCOM, INC.
    Inventors: Derek James Escobar, Naresh C. Bhavaraju, Gary A. Morris, Jorge Valdes